Over 12 months, MapLight Therapeutics, Inc. saw more selling than buying from its insiders — purchases of about $17 million against sales of $29.2 million.
Biggest single buyer: Novo Holdings A/S, 10% Owner, with roughly $16.2 million.
Zooming out by quarter: 3 quarters in a row of net selling by insiders. Insiders bought in 3 of the last 7 full quarters. On the institutional side, 106 funds reported holding MPLT at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Hanson Kristopher | Executive Officer | Sell | 16,509 | $11.67 | $193K | SEC |
| Aug 4, 2026 | Lillie James Woodruff | Executive Officer | Sell | 22,082 | $12.54 | $277K | SEC |
| Jul 28, 2026 | Cox Troy | Director | Buy | 15,620 | $9.52 | $149K | SEC |
| Jul 20, 2026 | GILLIS JONATHAN | CFO | Sell | 6,979 | $36.66 | $256K | SEC |
| Jul 20, 2026 | GILLIS JONATHAN | CFO | Sell | 1,476 | $37.44 | $55K | SEC |
| Jul 20, 2026 | GILLIS JONATHAN | CFO | Sell | 5,356 | $36.13 | $194K | SEC |
| Jul 20, 2026 | GILLIS JONATHAN | CFO | Sell | 4,699 | $36.94 | $174K | SEC |
| Jul 20, 2026 | GILLIS JONATHAN | CFO | Sell | 16,969 | $37.61 | $638K | SEC |
| Jul 20, 2026 | GILLIS JONATHAN | CFO | Sell | 600 | $36.51 | $22K | SEC |
| Jul 20, 2026 | GILLIS JONATHAN | CFO | Sell | 900 | $38.17 | $34K | SEC |
| Jul 20, 2026 | Kreitzer Anatol | Executive Officer | Sell | 1,592 | $37.44 | $60K | SEC |
| Jul 20, 2026 | Kreitzer Anatol | Executive Officer | Sell | 7,464 | $36.66 | $274K | SEC |
| Jul 20, 2026 | Kreitzer Anatol | Executive Officer | Sell | 4,510 | $36.94 | $167K | SEC |
| Jul 20, 2026 | Kreitzer Anatol | Executive Officer | Sell | 5,545 | $36.13 | $200K | SEC |
| Jul 20, 2026 | Kreitzer Anatol | Executive Officer | Sell | 200 | $38.39 | $8K | SEC |
In the last 12 months MapLight Therapeutics, Inc. insiders made open-market purchases worth about $17 million and sales worth about $29.2 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in MPLT was filed on 2026-09-18.
106 investment managers reported holding MPLT in SEC Form 13F filings for Q2 2026.
No congressional trades in MPLT were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).